NCT01860989View on ClinicalTrials.gov

A Study to Assess Efficacy, Safety of KAE609 in Adult Patients With Acute Malaria Mono-infection

PHASE2CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2014

Conditions
Cure Rate
Interventions
DRUG

KAE609

KAE609 75mg single dose

DRUG

KAE609

KAE609 150mg single dose

DRUG

KAE609

KAE609 225mg single dose

DRUG

KAE609

KAE609 300mg single dose

Trial Locations (4)

10000

Novartis Investigative Site, Hanoi

33140

Novartis Investigative Site, Si Sa Ket

63140

Novartis Investigative Site, Tak

70180

Novartis Investigative Site, Ratchabari

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY